Test Price
2,800 AED✅ Home Collection Available
UGT1A1 Gene Gilbert Syndrome Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين UGT1A1 لمتلازمة جيلبرت بتقنية NGS في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
- ✔ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS processing. دقة تشخيصية بنسبة 99.9% عبر مختبر معتمد ISO 9001:2015
- ✔ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain & VIP Mobile Phlebotomy (8 AM – 11 PM). خدمة سحب منزلي فاخرة عبر وحدة تبريد معتمدة ISO
- ✔ Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by DHA-licensed experts. إرشاد سريري هاتفي لتفسير النتائج بعد الفحص
- ✔ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731. التحقق من التغطية التأمينية عبر واتساب 971545488731+
💼 الامتثال التنظيمي
UAE Federal Decree‑Law No. 41 of 2024 (Art. 87)
CDS Law 2026 (Minors) Compliant
UAE PDPL (Federal Decree‑Law No. 45 of 2021) Compliant
Overview of UGT1A1 Gene Gilbert Syndrome Test
This next‑generation sequencing test screens the full UGT1A1 gene for variants that cause Gilbert syndrome, a benign hereditary unconjugated hyperbilirubinemia. يُجري هذا الاختبار تحليلاً متكاملاً لجين UGT1A1 لتأكيد متلازمة جيلبرت الحميدة، مما يمنع القلق غير الضروري والفحوصات البديلة المكلفة.
| Feature | Our Test (UAE – 2026 Standard) | Closest Alternative |
|---|---|---|
| Method | Next‑Generation Sequencing (NGS) with full gene coverage and CNV detection | PCR‑based single‑variant detection (e.g., TA‑repeat only) |
| Sensitivity | >99.9% for known and novel UGT1A1 variants | ~70‑80% (misses rare or promoter variants) |
| TAT | 3–4 Weeks (ISO‑accredited cold‑chain) | 1–2 Weeks (local methods, no clinical reporting) |
| Genetic Counseling | Included pre‑ and post‑test session | Not routinely provided |
| Regulatory Status | DHA‑licensed, ISO 9001:2015, UAE Genomics Law compliant | May not meet UAE laboratory standards |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY (DHA License: 61713011)
“A positive UGT1A1 variant is not a disease – Gilbert syndrome is a benign condition that does not require treatment; however, proper clinical correlation with bilirubin levels and symptoms is essential. Your test results must be reviewed by your doctor to rule out other liver abnormalities. Please note: Do not discontinue prescribed medication without consulting your doctor.”
⚠️ Exclusion Criteria & Emergency Red Flags
- Not for acute emergencies: This test is elective and not a substitute for urgent liver function evaluation.
- Exclusion: Patients with decompensated liver disease, current acute hepatitis, or known bilirubin encephalopathy should not delay immediate medical care.
- Seek ER immediately if you experience sudden severe jaundice, dark urine, clay‑colored stools, right upper abdominal pain, confusion, or swelling.
Patient FAQ & Clinical Guidance
1. What is the purpose of the UGT1A1 gene test, and is it really necessary if I have mild jaundice?
This test definitively diagnoses Gilbert syndrome, a harmless inherited condition, thereby eliminating the need for unnecessary and costly liver investigations.
يُثبت هذا الاختبار بشكل قاطع تشخيص متلازمة جيلبرت، وهو اضطراب وراثي حميد، مما يلغي الحاجة إلى فحوصات كبدية مكلفة وغير ضرورية.
2. Can I use a blood spot card (FTA card) for testing, and is it as accurate as a full blood draw?
DNA extracted from a single drop of blood on an FTA card yields the same high‑quality NGS results as a venous blood sample when processed under ISO‑controlled protocols.
يُنتج الحمض النووي المستخرج من قطرة دم واحدة على بطاقة FTA نفس نتائج NGS عالية الجودة التي تُحصل عليها من عينة الدم الوريدي عند اتباع بروتوكولات ISO.
3. Does the test cover all known UGT1A1 variants, and what if the result is negative but I still have symptoms?
Our NGS panel detects all clinically relevant promoter and coding region variants, but a negative result necessitates further hepatology evaluation for other hyperbilirubinemia causes.
يكتشف فحص NGS لدينا جميع المتغيرات الجينية ذات الأهمية السريرية، لكن ظهور نتيجة سلبية يستلزم تقييمًا إضافيًا من طبيب الكبد لاستبعاد أسباب أخرى لليرقان.
🔬 Methodology & LOINC
Next Generation Sequencing (NGS) – Full UGT1A1 gene analysis
LOINC: 77745-3 (loinc.org/77745-3)
🩺 2026 ICD‑10‑CM & Susceptibility
E80.4 Gilbert Syndrome
Z14.8 Genetic Susceptibility to Other Disease
Z13.79 Encounter for Genetic Screening
🏥 UAE Healthcare Accreditation
ISO 9001:2015 Cert: INT/EGQ/2509DA/3139
DHA Facility License: 9834453
Federal Genomics Law No. 29/2021
High‑relevance specialists ordering this: General Physician (initial recognition & referral), Primary Care Doctor (long‑term follow‑up), Medical & PhD Researcher (pharmacogenomic interpretation and novel variant analysis).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians